Hyperliquid director granted 40,789 share units

Hyperliquid Strategies Inc director Lawrence E. Leibowitz reported an equity award of 40,789 shares of common stock, recorded as a grant under a Form 4 filing.

Rhea-AI Filing Summary

Hyperliquid Strategies Inc director Lawrence E. Leibowitz reported an equity award of 40,789 shares of common stock, recorded as a grant under a Form 4 filing. The award is in the form of restricted stock units that carry a price of $0 per unit.

The filing shows he beneficially owns 80,589 common shares after this grant. These restricted stock units are scheduled to vest over three years, with one-third vesting on each of December 2, 2026, December 2, 2027, and December 2, 2028.

Insider Trade Summary

Grant/Award: 40,789 shares

Grant/Award 1 txn

Insider LEIBOWITZ LAWRENCE E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	40,789	$0.00	$0.00

Holdings After Transaction: Common Stock — 80,589 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Hyperliquid Strategies Inc (PURR) report?

Hyperliquid Strategies Inc reported an equity award to director Lawrence E. Leibowitz of 40,789 shares of common stock. The award is structured as restricted stock units with no cash price, increasing his beneficial ownership to 80,589 shares following the transaction.

Who is the reporting person in the Hyperliquid Strategies Inc (PURR) Form 4?

The reporting person is Lawrence E. Leibowitz, a director of Hyperliquid Strategies Inc. The Form 4 shows his acquisition of restricted stock units and confirms his role as a board member rather than an officer or 10% owner of the company.

How many Hyperliquid Strategies Inc (PURR) shares did the director acquire?

Director Lawrence E. Leibowitz acquired 40,789 shares of Hyperliquid Strategies Inc common stock through a grant. These are recorded as restricted stock units, bringing his total beneficial ownership after the transaction to 80,589 common shares held directly.

What is the vesting schedule for the Hyperliquid Strategies Inc (PURR) restricted stock units?

The restricted stock units vest in three equal installments over three years. One-third vests on December 2, 2026, another third on December 2, 2027, and the final third on December 2, 2028, subject to the award’s standard conditions.

What was the transaction price for the Hyperliquid Strategies Inc (PURR) equity grant?

The Form 4 reports a transaction price of $0 per share for the 40,789 common shares granted. This reflects that the award is a restricted stock unit grant, not an open-market purchase, and is typically part of director compensation.

Is the Hyperliquid Strategies Inc (PURR) Form 4 transaction a buy or a grant?

The transaction is a grant, not a market buy. It is coded as an acquisition due to a grant, award, or other acquisition, and is specifically described as restricted stock units granted to the director as part of his compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/11/2026 - 07:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LEIBOWITZ LAWRENCE E

(Last) (First) (Middle)

C/O HYPERLIQUID STRATEGIES INC

477 MADISON AVENUE, 22ND FLOOR

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hyperliquid Strategies Inc [ PURR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		A		40,789	A(1)	$0(1)	80,589	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each of December 2, 2026, December 2, 2027 and December 2, 2028.

	/s/ Jason T. Simon, Attorney-in-Fact	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.